About Micropharma
Micropharma is a Healthcare company based in Montreal (Canada) founded in 2004 by Satya Prakash, and was acquired by UAS Labs in December 2014. Biotherapeutics for metabolic diseases are developed from bacteria. Micropharma has raised $851.24 thousand across 1 funding round from investors including UAS Labs. The company was acqui-hired. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Viral.
Company details
Micropharma was founded in 2004 in Montreal, Canada, within the biotherapeutics sector focused on metabolic diseases. Bacteria are discovered and developed as treatments through the proprietary ProSelect platform, which identifies strains expressing targeted phenotypic traits in metabolic pathways. Fermentation and optimization techniques are applied to enhance trait over-expression. Cardioviva, a bile-salt-hydrolase active bacterium, was developed. The company was acquired by UAS Labs in 2014.
- Headquarters Montreal, Canada
- Founders Satya Prakash
- Stage Acquired
- SectorsHealthcare
- Website micropharma.net
- Social LinkedIn Facebook
- Acquired by UAS Labs (Dec 2014)
Funding Insights of Micropharma
Micropharma has successfully raised a total of $851.24K through 1 strategic funding round. The most recent funding activity was a Seed round of $851.24 thousand completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $851,242
- Total Rounds 1
- Last Round Seed — $851,242
- First Round $851,242
(Jan 2013)
All 1 funding rounds of Micropharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2013 | $851,242 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Micropharma
Micropharma has secured backing from 1 investor. Prominent investors backing the company include UAS Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical research and probiotic fermentation services are provided. | 1979 | uaslabs.com | Wausau, United States |
Investor details for Micropharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Micropharma
1 people are tracked at Micropharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Satya Prakash | Founder | Leadership |
Complete people profiles for Micropharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Micropharma
3 dated milestones of Micropharma across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Micropharma is founded.
- Funding First funding round of $851K.
- Exit Acquired by UAS Labs.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Micropharma
Micropharma was founded in 2004 and raised its 1st funding round 9 years after it was founded.
Micropharma is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Micropharma is a funded company, having raised a total of $851.24K across 1 funding round to date. The company's 1st funding round was a Seed of $851.24K, raised on Jan 2013.
Micropharma was founded in 2004 in Montreal, Canada, within the biotherapeutics sector focused on metabolic diseases. Bacteria are discovered and developed as treatments through the proprietary ProSelect platform, which identifies strains expressing targeted phenotypic traits in metabolic pathways. Fermentation and optimization techniques are applied to enhance trait over-expression. Cardioviva, a bile-salt-hydrolase active bacterium, was developed. The company was acquired by UAS Labs in 2014.
Micropharma has 1 investor. Key investors include UAS Labs.
Yes. Micropharma was acquired by UAS Labs in December 2014.